Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026)
Becton Dickinson's (BDX) quarterly Income from Continuing Operations came in at 37000000.0 in Q1 2026, down 123.42% year-on-year from 158000000.0 in Q1 2025, and down 109.69% on a QoQ basis from 382000000.0 in Q4 2025.
Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Income from Continuing Operations data on file, last reported at 37000000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 123.42% year-over-year to 37000000.0 in Q1 2026; TTM through Mar 2026 was 1412000000.0, a 4.75% increase from a year earlier, with the FY2025 full-year figure at 1678000000.0, down 1.58% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 37000000.0, down from 382000000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for BDX reached as high as 574000000.0 in Q2 2025 and fell as low as 37000000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 363294117.65 across 5 years, with a median of 390000000.0 in 2022.
- Across the five-year window, Income from Continuing Operations soared 161.44% in 2024 and sank 123.42% in 2026, its largest moves.
- Year by year, Income from Continuing Operations stood at 509000000.0 in 2022, then sank by 44.6% to 282000000.0 in 2023, then rose by 7.45% to 303000000.0 in 2024, then advanced by 26.07% to 382000000.0 in 2025, then slumped by 109.69% to 37000000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 37000000.0 in Q1 2026, 382000000.0 in Q4 2025, and 493000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 493.00 Mn |
| Jun 30, 2025 | 574.00 Mn |
| Mar 31, 2025 | 158.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 487.00 Mn |
| Mar 31, 2024 | 537.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 153.00 Mn |
| Jun 30, 2023 | 407.00 Mn |
| Mar 31, 2023 | 461.00 Mn |
| Dec 31, 2022 | 509.00 Mn |
| Sep 30, 2022 | 287.00 Mn |
| Jun 30, 2022 | 390.00 Mn |
| Mar 31, 2022 | 390.00 Mn |
| Dec 31, 2021 | 568.00 Mn |
| Sep 30, 2021 | 155.00 Mn |
| Jun 30, 2021 | 406.00 Mn |